Conversely, low molecular weight HA exerts a pro-tumourigenic effect, competing with native-HA for binding to the CD44 receptor, thereby preventing the beneficial clustering of CD44 and enabling tumour progression by inhibiting Hippo signalling. The gene discussed is CD44; the disease is neoplasm.